Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 646 items for :

  • "tumor progression" x
  • Refine by access: All content x
Clear All
Elena Valassi IIB-Sant Pau and Department of Endocrinology/Medicine, Hospital Sant Pau and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, Barcelona, Spain
Universitat Internacional de Catalunya (UIC), Barcelona, Spain

Search for other papers by Elena Valassi in
Google Scholar
PubMed Close
,
Frédéric Castinetti Department of Endocrinology, Aix Marseille University, AP-HM, INSERM, Marseille Medical Genetics, Marmara Institute, La Conception Hospital, Marseille, France

Search for other papers by Frédéric Castinetti in
Google Scholar
PubMed Close
,
Amandine Ferriere Department of Endocrinology, Diabetes and Nutrition, University of Bordeaux, Bordeaux, France

Search for other papers by Amandine Ferriere in
Google Scholar
PubMed Close
,
Stylianos Tsagarakis Department of Endocrinology, Diabetes and Metabolism, Evangelismos Hospital, Athens, Greece

Search for other papers by Stylianos Tsagarakis in
Google Scholar
PubMed Close
,
Richard A Feelders Erasmus Medical Center, Division of Endocrinology, Department of Internal Medicine, Rotterdam, The Netherlands

Search for other papers by Richard A Feelders in
Google Scholar
PubMed Close
,
Romana T Netea-Maier Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed Close
,
Michael Droste Praxis für Endokrinologie Dr. med. Michael Droste, Oldenburg, Germany

Search for other papers by Michael Droste in
Google Scholar
PubMed Close
,
Christian J Strasburger Division of Clinical Endocrinology, Department of Medicine CCM, Charité-Universitätsmedizin, Berlin, Germany

Search for other papers by Christian J Strasburger in
Google Scholar
PubMed Close
,
Dominique Maiter Service d’Endocrinologie et Nutrition, Cliniques universitaires Saint Luc, Brussels, Belgium

Search for other papers by Dominique Maiter in
Google Scholar
PubMed Close
,
Darko Kastelan Department of Endocrinology, University Hospital Zagreb, Zagreb, Croatia

Search for other papers by Darko Kastelan in
Google Scholar
PubMed Close
,
Philippe Chanson Institut National de la Santé et de la Recherche Médicale, U1185, Le Kremlin, Bicêtre, Paris, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close
,
Susan M Webb IIB-Sant Pau and Department of Endocrinology/Medicine, Hospital Sant Pau and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, Barcelona, Spain
Universitat Autònoma de Barcelona (UAB), Barcelona, Spain

Search for other papers by Susan M Webb in
Google Scholar
PubMed Close
,
Frank Demtröder Zentrum für Endokrinologie, Diabetologie, Rheumatologie Dr. Demtröder & Kollegen, Dortmund, Germany

Search for other papers by Frank Demtröder in
Google Scholar
PubMed Close
,
Valdis Pirags Paula Stradiņa klīniskā universitātes slimnīca, Riga, Latvia

Search for other papers by Valdis Pirags in
Google Scholar
PubMed Close
,
Olivier Chabre Hospitalier Universitaire, Grenoble, France

Search for other papers by Olivier Chabre in
Google Scholar
PubMed Close
,
Holger Franz Lohmann & Birkner Health Care Consultimg GmbH, Berlin, Germany

Search for other papers by Holger Franz in
Google Scholar
PubMed Close
,
Alicia Santos IIB-Sant Pau and Department of Endocrinology/Medicine, Hospital Sant Pau and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, Barcelona, Spain
Universitat Autònoma de Barcelona (UAB), Barcelona, Spain

Search for other papers by Alicia Santos in
Google Scholar
PubMed Close
, and
Martin Reincke Medizinische Klinik UND Poliklinik IV, Campus Innestadt, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Martin Reincke in
Google Scholar
PubMed Close

( Fountas & Karavitaki 2020 ). A recent consensus recognized the presence of an expanding adenoma on imaging as the most accurate diagnostic criterion of NS and, accordingly, proposed the definition of ‘corticotroph tumor progression after bilateral

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0074
Volume/Issue:
Volume 29: Issue 12
Restricted access
Anna Bagnato Molecular Pathology and Ultrastructure Laboratory, Regina Elena Cancer Institute, Via delle Messi d’Oro 156, 00158 Rome, Italy

Search for other papers by Anna Bagnato in
Google Scholar
PubMed Close
,
Francesca Spinella Molecular Pathology and Ultrastructure Laboratory, Regina Elena Cancer Institute, Via delle Messi d’Oro 156, 00158 Rome, Italy

Search for other papers by Francesca Spinella in
Google Scholar
PubMed Close
, and
Laura Rosanò Molecular Pathology and Ultrastructure Laboratory, Regina Elena Cancer Institute, Via delle Messi d’Oro 156, 00158 Rome, Italy

Search for other papers by Laura Rosanò in
Google Scholar
PubMed Close

patients in advanced stages is still associated by low survival rates, the development of new treatment protocols depends on improved knowledge of the molecular mechanisms controlling tumor progression ( Naora & Montell 2005 ). Cancer invasion is a state

Article Type:
Review Article
DOI:
https://doi.org/10.1677/erc.1.01077
Volume/Issue:
Volume 12: Issue 4
Free access
Yvonne Fierz Division of Endocrinology, Diabetes and Bone Diseases, The Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA

Search for other papers by Yvonne Fierz in
Google Scholar
PubMed Close
,
Ruslan Novosyadlyy Division of Endocrinology, Diabetes and Bone Diseases, The Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA

Search for other papers by Ruslan Novosyadlyy in
Google Scholar
PubMed Close
,
Archana Vijayakumar Division of Endocrinology, Diabetes and Bone Diseases, The Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA

Search for other papers by Archana Vijayakumar in
Google Scholar
PubMed Close
,
Shoshana Yakar Division of Endocrinology, Diabetes and Bone Diseases, The Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA

Search for other papers by Shoshana Yakar in
Google Scholar
PubMed Close
, and
Derek LeRoith Division of Endocrinology, Diabetes and Bone Diseases, The Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA

Search for other papers by Derek LeRoith in
Google Scholar
PubMed Close

the setting of type 2 diabetes are largely unknown. To study the effect of mTOR blockade on type 2 diabetes-induced mammary tumor progression, we employed a hyperinsulinemic mouse model of type 2 diabetes, the female MKR mice. These mice overexpress

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-10-0091
Volume/Issue:
Volume 17: Issue 4
Free access
A Bardin
Search for other papers by A Bardin in
Google Scholar
PubMed Close
,
N Boulle
Search for other papers by N Boulle in
Google Scholar
PubMed Close
,
G Lazennec
Search for other papers by G Lazennec in
Google Scholar
PubMed Close
,
F Vignon
Search for other papers by F Vignon in
Google Scholar
PubMed Close
, and
P Pujol
Search for other papers by P Pujol in
Google Scholar
PubMed Close

feature of estrogen-dependent tumor progression in clinical studies Analysis of ERα and ERβ expression in estrogen-sensitive cancers (Tables 1–4) In breast tissues, several studies have indicated an increase in ERα/ERβ mRNA

Article Type:
Research Article
DOI:
https://doi.org/10.1677/erc.1.00800
Volume/Issue:
Volume 11: Issue 3
Free access
Annu Makker Post Graduate Department of Pathology, King George's Medical University, Lucknow 226003, Uttar Pradesh, India

Search for other papers by Annu Makker in
Google Scholar
PubMed Close
and
Madhu Mati Goel Post Graduate Department of Pathology, King George's Medical University, Lucknow 226003, Uttar Pradesh, India

Search for other papers by Madhu Mati Goel in
Google Scholar
PubMed Close

in CTNNB1 , PPP21A , and p53 genes have been suggested to contribute to tumor progression from EEC to UEC ( Kuhn et al . 2014 ). Although the overall 5-year survival rate in patients with stage I EEC approaches 90%, ∼30% of these tumors are high

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-15-0218
Volume/Issue:
Volume 23: Issue 2
Free access
Zane Hammoud Department of Obstetrics and Gynecology, Thoracic Surgery, Pathology, Indiana University School of Medicine, 975 West Walnut Street (IB360), Indianapolis, Indiana 46202-5121, USA Departments of

Search for other papers by Zane Hammoud in
Google Scholar
PubMed Close
,
Bailin Tan
Search for other papers by Bailin Tan in
Google Scholar
PubMed Close
,
Sunil Badve Department of Obstetrics and Gynecology, Thoracic Surgery, Pathology, Indiana University School of Medicine, 975 West Walnut Street (IB360), Indianapolis, Indiana 46202-5121, USA Departments of

Search for other papers by Sunil Badve in
Google Scholar
PubMed Close
, and
Robert M Bigsby
Search for other papers by Robert M Bigsby in
Google Scholar
PubMed Close

that estrogen increased tumor grade in males ( P <0.001), but not in ovariectomized females ( Fig. 4 ). Figure 4 Effect of estradiol on tumor progression. Using a scale described by Jackson et al . (2005) for grading mouse lung tumors, histological

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-08-0002
Volume/Issue:
Volume 15: Issue 2
Free access
Louis de Mestier
Search for other papers by Louis de Mestier in
Google Scholar
PubMed Close
,
Clarisse Dromain Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Clarisse Dromain in
Google Scholar
PubMed Close
,
Gaspard d'Assignies Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Gaspard d'Assignies in
Google Scholar
PubMed Close
,
Jean-Yves Scoazec Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Jean-Yves Scoazec in
Google Scholar
PubMed Close
,
Nathalie Lassau Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Nathalie Lassau in
Google Scholar
PubMed Close
,
Rachida Lebtahi Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Rachida Lebtahi in
Google Scholar
PubMed Close
,
Hedia Brixi
Search for other papers by Hedia Brixi in
Google Scholar
PubMed Close
,
Emmanuel Mitry Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Emmanuel Mitry in
Google Scholar
PubMed Close
,
Rosine Guimbaud Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Rosine Guimbaud in
Google Scholar
PubMed Close
,
Frédéric Courbon Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Frédéric Courbon in
Google Scholar
PubMed Close
,
Michèle d'Herbomez Department of Hepato-Gastroenterology and Digestive Oncology, Department of Radiology, Department of Radiology, Department of Pathology, Integrated Research Cancer Institute in Villejuif, Department of Nuclear Medicine, Department of Medical Oncology, Department of Digestive Oncology, Department of Nuclear Medicine, Department of Biology and Pathology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

Search for other papers by Michèle d'Herbomez in
Google Scholar
PubMed Close
, and
Guillaume Cadiot
Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed Close

SD: no criteria for CR, PR, or PD and no symptomatic deterioration attributed to tumor progression PD: ≥10% increase in the sum of diameters, increase in size of existing intra-tumoral nodules, new lesion, or intra-tumor nodule Chun

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-13-0365
Volume/Issue:
Volume 21: Issue 3
Free access
Teresa Ramone Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Teresa Ramone in
Google Scholar
PubMed Close
,
Cristina Romei Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Cristina Romei in
Google Scholar
PubMed Close
,
Raffaele Ciampi Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Raffaele Ciampi in
Google Scholar
PubMed Close
,
Roberta Casalini Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Roberta Casalini in
Google Scholar
PubMed Close
,
Angelo Valetto Department of Laboratory Medicine, Section of Cytogenetics, University Hospital of Pisa, Pisa, Italy

Search for other papers by Angelo Valetto in
Google Scholar
PubMed Close
,
Veronica Bertini Department of Laboratory Medicine, Section of Cytogenetics, University Hospital of Pisa, Pisa, Italy

Search for other papers by Veronica Bertini in
Google Scholar
PubMed Close
,
Francesco Raimondi Laboratorio di Biologia Bio@SNS, Scuola Normale Superiore, Pisa, Italy

Search for other papers by Francesco Raimondi in
Google Scholar
PubMed Close
,
Anthony Onoja Laboratorio di Biologia Bio@SNS, Scuola Normale Superiore, Pisa, Italy

Search for other papers by Anthony Onoja in
Google Scholar
PubMed Close
,
Alessandro Prete Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Alessandro Prete in
Google Scholar
PubMed Close
,
Antonio Matrone Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Antonio Matrone in
Google Scholar
PubMed Close
,
Carla Gambale Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Carla Gambale in
Google Scholar
PubMed Close
,
Paolo Piaggi Department of Information Engineering, University of Pisa, Pisa, Italy

Search for other papers by Paolo Piaggi in
Google Scholar
PubMed Close
,
Liborio Torregrossa Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Pathology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed Close
,
Clara Ugolini Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Pathology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Clara Ugolini in
Google Scholar
PubMed Close
, and
Rossella Elisei Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close

et al. 2007 ). In fact, the amplification of chromosomal regions containing oncogenes involved in tumor progression or the loss of regions containing TSG could justify the correlation between SCNA and metastatic progression and poor outcomes of the

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0251
Volume/Issue:
Volume 30: Issue 9
Restricted access
Nikki A Ford Department of Nutritional Sciences, Department of Molecular Carcinogenesis, Dell Pediatric Research Institute, University of Texas, 1400 Barbara Jordan Boulevard, DPRI 2.834, Austin, Texas 78722, USA

Search for other papers by Nikki A Ford in
Google Scholar
PubMed Close
,
Nomeli P Nunez Department of Nutritional Sciences, Department of Molecular Carcinogenesis, Dell Pediatric Research Institute, University of Texas, 1400 Barbara Jordan Boulevard, DPRI 2.834, Austin, Texas 78722, USA

Search for other papers by Nomeli P Nunez in
Google Scholar
PubMed Close
,
Valerie B Holcomb Department of Nutritional Sciences, Department of Molecular Carcinogenesis, Dell Pediatric Research Institute, University of Texas, 1400 Barbara Jordan Boulevard, DPRI 2.834, Austin, Texas 78722, USA

Search for other papers by Valerie B Holcomb in
Google Scholar
PubMed Close
, and
Stephen D Hursting Department of Nutritional Sciences, Department of Molecular Carcinogenesis, Dell Pediatric Research Institute, University of Texas, 1400 Barbara Jordan Boulevard, DPRI 2.834, Austin, Texas 78722, USA
Department of Nutritional Sciences, Department of Molecular Carcinogenesis, Dell Pediatric Research Institute, University of Texas, 1400 Barbara Jordan Boulevard, DPRI 2.834, Austin, Texas 78722, USA

Search for other papers by Stephen D Hursting in
Google Scholar
PubMed Close

). Furthermore, the Met1 cell line, derived from a spontaneous tumor from a polyoma middle-T antigen transgenic mouse, progressively loses ER and progesterone receptor positivity with tumor progression, therefore providing a rapid and relevant model for studying

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0329
Volume/Issue:
Volume 20: Issue 1
Free access
Clay E S Comstock Department of Cancer Biology, Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 233 S 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 233 S 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA

Search for other papers by Clay E S Comstock in
Google Scholar
PubMed Close
and
Karen E Knudsen Department of Cancer Biology, Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 233 S 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 233 S 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 233 S 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 233 S 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA

Search for other papers by Karen E Knudsen in
Google Scholar
PubMed Close

with the conclusion that tumor progression is largely driven by resurgent AR activity, hormone therapy ‘failure’ is typically first detected by a rise in PSA despite the maintenance of ligand depletion and AR-directed therapeutic regimens, indicating

Article Type:
Article Commentary
DOI:
https://doi.org/10.1530/ERC-13-0243
Volume/Issue:
Volume 20: Issue 5
Free access